Determination of carbohydrate structures N-linked to soluble CD154 and characterization of the interactions of CD40 with CD154 expressed in Pichia pastoris and Chinese hamster ovary cells

Protein Expression and Purification

Volumn 23, Issue 2, 2001, Pages 301-310

  Khandekar, Sanjay S ^a,b   Silverman, Carol ^a,b   Wells Marani, Jennifer ^a,b   Bacon, Alicia M ^a,b   Birrell, Helen ^b   Brigham Burke, Michael ^a,b   DeMarini, Douglas J ^a,b   Jonak, Zdenka L ^a,b   Camilleri, Patrick ^b   Fishman Lobell, Jacqueline ^a,b  

^a Department of Oncology Research ^*

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ASPARAGINE; B LYMPHOCYTE; BINDING SITE; CARBOHYDRATE; CARBOHYDRATE ANALYSIS; CD40 ANTIGEN; CHEMICAL STRUCTURE; GLYCOSYLATION; IMMUNITY; LIGAND BINDING; MANNOSE; MONOMER; PURIFICATION; REACTION MECHANISM;

CRICETINAE; CRICETULUS GRISEUS; PICHIA PASTORIS;

EID: 0034762145     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2001.1501     Document Type: Article

References (44)

1. The hyper-IGM (HIM) syndrome
2. The CD40 antigen and its ligand
3. CD40-CD154 interaction in experimental and human disease
4. Immune regulation by CD40 and its ligand GP39
5. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines
6. Activation of human dendritic cells through CD40 cross-linking
7. Stimulation of CD40 with purified soluble GP39 induces proinflammatory responses in human monocytes
8. Anti-immunoglobulin and anti-CD40 stimulation induces CD25 expression by resting human tonsillar B lymphocytes
9. Recombinant soluble trimeric CD40 ligand is biologically active
10. Expression of trimeric CD40 ligand in Pichia pastoris - Use of a rapid method to detect high-level expressing transformants
11. Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154)
12. Human native soluble CD40L is a biologically active trimer, processed inside microsomes
13. Induction, regulation, and function of soluble trap (CD40 ligand) during interaction of primary CD4(+) CD45RA(+) T cells with dendritic cells
14. A soluble form of trap (CD40 ligand) is rapidly released after T cell activation
15. The soluble CD40 ligand sCD154 in systemic lupus erythematosus
16. 2 angstrom crystal structure of an extracellular fragment of human CD40 ligand
17. Analysis of GP39/CD40 interactions using molecular models and site-directed mutagenesis
18. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction
19. N-glycosylation is required for human CD2 immunoadhesion functions
20. Cells regulate the activities of cytokines by glycosylation
21. O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity
22. Effect of glycosylation of recombinant human granulocytic colony-stimulating factor on expansion cultures of umbilical cord blood CD34(+) cells
23. Effect of carbohydrates on the pharmacokinetics of human interferon-gamma
24. N-Glycosylation of human interferon-gamma: Glycans at Asn-25 are critical for protease resistance
25. Granulocyte-macrophage colony stimulating factor from human lymphocytes: The effect of glycosylation on receptor binding and biological activity
26. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2) - Analysis by site directed mutagenesis
27. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas
28. Expression and purification of stable 33-kDa soluble human CD23 using the Drosophila S2 expression system
29. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity
30. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth
31. Cleavage of structural proteins during assembly of the head of the bacteriophage T4
32. Expression, purification and crystallization of the Escherichia coli selenomethionyl beta-ketoacyl-acyl carrier protein synthase III
33. Antibodies to TR2 (herpesvirus entry mediator), a new member of the tnf receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines
34. Defining the structure and stability of macromoleculear assemblies in solution the re-emergence of analytical ultracentrifugation as a practical tool
35. A dual-detection strategy in the chromatographic analysis of 2-aminoacridone-derivatized oligosaccharides
36. Glycoprotein biosynthesis in yeast
37. Structure of yeast external invertase Man8-14GlcNAc processing intermediates by 500-megahertz 1H NMR spectroscopy
38. Structure of oligosaccharides on Saccharomyces SUC2 invertase secreted by the methylotrophic yeast Pichia pastoris
39. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
40. Conformational integrity and ligand binding properties of a single chain T-cell receptor expressed in Escherichia coli
41. Affinity and kinetics of the interactions between an alpha-beta T-cell receptor and its superantigen and class II-MHC/peptide ligands
42. Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes
43. Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (ifn-beta)